AGN - Allergan plc
Previous close
193.02
0 0%
Share volume: 0
Last Updated: Fri 08 May 2020 06:00:00 AM CEST
Pharmaceuticals: Generic:
0.49%
PREVIOUS CLOSE
CHG
CHG%
$193.02
0.00
0.00%
Summary score
36%
Profitability
19%
Dept financing
15%
Liquidity
53%
Performance
53%
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-0.37%
Return on assets
0.09%
Return on sales
1.56%
Return on invested capital
-0.12%
Total debt ratio
37.78%
Debt ratio change over timeo
-107.32%
Current Ratio
1.31%
Quick Ratio
1.19%
Cash Position Ratio
0.21%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.05%
Return on assets
0.31%
Return on sales
6.88%
Return on invested capital
-0.8%
Total debt ratio
37.14%
Debt ratio change over timeo
-37.36%
Current Ratio
1.01%
Quick Ratio
0.89%
Cash Position Ratio
0.17%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
0.65%
Return on assets
-0.08%
Return on sales
-2.01%
Return on invested capital
0.51%
Total debt ratio
34.41%
Debt ratio change over time
-79.65%
Current Ratio
1.01%
Quick Ratio
0.84%
Cash Position Ratio
0.13%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
1075.01%
Return on assets
-91.72%
Return on sales
471.35%
Return on invested capital
727.49%
Total debt ratio
-10732.04%
Debt ratio change over time
-107.32%
Current Ratio
-378%
Quick Ratio
-339.81%
Cash Position Ratio
-57.74%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AGN | MYL | ABEOW | PETX |
|---|---|---|---|---|
| Return on equity | -0.37% | 0.8% | 0% | -10.54% |
| Return on assets | 0.09% | 0.95% | 0% | -5.69% |
| Return on sales | 1.56% | 10.77% | 0% | -3529.01% |
| Return on invested capital | -0.12% | 0.43% | 0% | -43.38% |
| Profitability | 6% | 100% | 0% | 0% |
| Total debt ratio | 37.78% | 63.87% | 0% | 28.72% |
| Debt ratio change over time | -107.32% | 56.58% | 0% | -1.64% |
| Dept financing | 15% | 50% | 0% | 11% |
| Current Ratio | 1.01% | 1.34% | 0% | 0% |
| Quick Ratio | 0.89% | 0.78% | 0% | 0% |
| Cash Position Ratio | 0.17% | 0.07% | 0% | 0% |
| Liquididy | 17% | 14% | 0% | 75% |
| Short-term ratios | AGN | MYL | ABEOW | PETX |
|---|---|---|---|---|
| Return on equity | -1.05% | 0.14% | 0% | 0% |
| Return on assets | 0.31% | 0.97% | 0% | 0% |
| Return on sales | 6.88% | 10.04% | 0% | 0% |
| Return on invested capital | -0.8% | 0.09% | 0% | 0% |
| Profitability | 25% | 100% | 0% | 0% |
| Total debt ratio | 37.14% | 62.55% | 0% | 0% |
| Debt ratio change over time | -37.36% | -185% | 0% | 0% |
| Dept financing | 15% | 25% | 25% | 0% |
| Current Ratio | 1.01% | 1.34% | 0% | 0% |
| Quick Ratio | 0.89% | 0.78% | 0% | 0% |
| Cash Position Ratio | 0.17% | 0.07% | 0% | 0% |
| Liquididy | 69% | 57% | 0% | 0% |